SourceFrontiers Media SAProduction of gene-edited cloned cattle embryos using the CRISPR/EOCas12i system
- Publisher
- Frontiers Media SA
- Date
- Jul 6, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceElsevier BVRational design of an ERA-assisted CRISPR/Cas12a platform for rapid and precise on-site detection of gene-edited rice
- Publisher
- Elsevier BV
- Date
- Jul 3, 2026
- Trust tier
- openalex
- License
- Not specified
SourceOpenAlex indexed sourceNext-Generation Functional Genomics
- Publisher
- OpenAlex indexed source
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- Not specified
SourceOriental Scientific Publishing CompanyGene Therapy and CRISPR-based Intervention in Sickle Cell Anemia
- Publisher
- Oriental Scientific Publishing Company
- Date
- Jun 25, 2026
- Trust tier
- openalex
- License
- cc-by
SourcePreprints.orgFaster, Smarter, Precise: Integrating Speed Breeding and CRISPR-Based New Genomic Techniques into the Conventional Cereal Breeding Pipeline
- Publisher
- Preprints.org
- Date
- Jul 7, 2026
- Trust tier
- openalex
- License
- cc-by
SourceSpringer Science and Business Media LLCA streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9
- Publisher
- Springer Science and Business Media LLC
- Date
- Jun 26, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0
SourceResearch SquareCRISPR-Cas9–Mediated Genome Editing in Avocado: Advances in Editing Efficiency and Regeneration
- Publisher
- Research Square
- Date
- Jun 22, 2026
- Trust tier
- openalex
- License
- cc-by
SourceOpenAlex indexed sourceEpigenome Editing for Gene Regulation and Therapeutics
- Publisher
- OpenAlex indexed source
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- Not specified
SourcePublic Library of ScienceHighly frequent undesired insertional mutagenesis during Drosophila genome editing
- Publisher
- Public Library of Science
- Date
- Jul 9, 2026
- Trust tier
- openalex
- License
- cc-by
SourceOpenAlex indexed sourceCRISPR-Cas Genome Editing and Artificial Intelligence for Resilient Crop Disease Control
- Publisher
- OpenAlex indexed source
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- Not specified
SourceEuropean Organization for Nuclear ResearchRecent Advancements in Genetic Engineering: CRISPR Technology and Gene Therapy Applications
- Publisher
- European Organization for Nuclear Research
- Date
- Jun 19, 2026
- Trust tier
- openalex
- License
- cc-by
SourceNature PortfolioIdentifying critical lysines in mammalian histone H3 with high-throughput CRISPR prime editing
- Publisher
- Nature Portfolio
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- cc-by
SourceHanif Medisiana PublisherSafety and Efficacy of Subretinal AAV-CRISPR/Cas9 Gene Editing for Rhodopsin-Mutant Retinitis Pigmentosa: A Phase I/IIa Dose-Escalation Triall
- Publisher
- Hanif Medisiana Publisher
- Date
- Jun 19, 2026
- Trust tier
- crossref
- License
- Not specified
SourceCureus, Inc.Focal Polycomb-Mediated Repression of Neuronal Identity and Synaptic Maintenance Genes in Aging Neurons
- Publisher
- Cureus, Inc.
- Date
- Jun 30, 2026
- Trust tier
- openalex
- License
- cc-by
SourceClinicalTrials.govHematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease
- Publisher
- ClinicalTrials.gov
- Date
- Jul 16, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceClinicalTrials.govAAVrh10-PCCA Gene Therapy for Propionic Acidemia
- Publisher
- ClinicalTrials.gov
- Date
- Jun 23, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceEuropean Organization for Nuclear ResearchRecent Advancements in Genetic Engineering: CRISPR Technology and Gene Therapy Applications
- Publisher
- European Organization for Nuclear Research
- Date
- Jun 19, 2026
- Trust tier
- openalex
- License
- cc-by
SourceClinicalTrials.govEvaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
- Publisher
- ClinicalTrials.gov
- Date
- Jul 1, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceWileyEffect of
<scp>BRD0539</scp>
on Gene Editing and Mosaicism Rate in Porcine Gene Editing Embryos by
<scp>CRISPR</scp>
/Cas9
- Publisher
- Wiley
- Date
- Jun 29, 2026
- Trust tier
- crossref
- License
- http://onlinelibrary.wiley.com/termsAndConditions#vor
SourcePeerJ, Inc.Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas genome editing transforming crop stress tolerance for global food security
- Publisher
- PeerJ, Inc.
- Date
- Jul 1, 2026
- Trust tier
- openalex
- License
- cc-by
SourceAcademy of Medicine, SingaporeGene editing and evo devo taxonomy in plant research
- Publisher
- Academy of Medicine, Singapore
- Date
- Jul 16, 2026
- Trust tier
- openalex
- License
- cc-by-nc-nd
SourceUttar Pradesh Zoological SocietyFunctional Genomics in Zoology: Harnessing CRISPR-Cas Mechanisms and Applications
- Publisher
- Uttar Pradesh Zoological Society
- Date
- Jul 8, 2026
- Trust tier
- openalex
- License
- cc-by
SourceElsevier BVCRISPR/Cas9-based targeted Lipoxygenase-2 gene editing in mungbean via transient transformation assays
- Publisher
- Elsevier BV
- Date
- Jul 1, 2026
- Trust tier
- crossref
- License
- https://www.elsevier.com/tdm/userlicense/1.0/
SourceMultidisciplinary Digital Publishing InstituteCRISPR Gene Tagging for Illuminating Endogenous Protein Dynamics
- Publisher
- Multidisciplinary Digital Publishing Institute
- Date
- Jun 20, 2026
- Trust tier
- openalex
- License
- cc-by
SourceOxford University PressA versatile tool for gene editing in the diatom <i>Thalassiosira pseudonana</i>
- Publisher
- Oxford University Press
- Date
- Jun 30, 2026
- Trust tier
- openalex
- License
- Not specified
SourceSpringer NatureProgrammable enhancement of endogenous mRNA translation through CRISPR-guided epitranscriptomic regulation
- Publisher
- Springer Nature
- Date
- Jun 24, 2026
- Trust tier
- openalex
- License
- cc-by
SourceSpringer Science and Business Media LLCDaily briefing: Editing the epigenome with CRISPR to treat disease
- Publisher
- Springer Science and Business Media LLC
- Date
- Jun 29, 2026
- Trust tier
- crossref
- License
- https://www.springernature.com/gp/researchers/text-and-data-mining
SourceElsevier BVNext-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
- Publisher
- Elsevier BV
- Date
- Jul 1, 2026
- Trust tier
- crossref
- License
- https://www.elsevier.com/tdm/userlicense/1.0/
SourceHong Kong Libo Information Consulting LimitedCRISPR/Cas9 in red blood cell-related diseases: breakthroughs in gene editing and therapy
- Publisher
- Hong Kong Libo Information Consulting Limited
- Date
- Jun 30, 2026
- Trust tier
- crossref
- License
- Not specified
SourceeLife Sciences Publications LtdArrayed single-gene perturbations identify drivers of human anterior neural tube closure
- Publisher
- eLife Sciences Publications Ltd
- Date
- Jul 7, 2026
- Trust tier
- openalex
- License
- cc-by
SourceSpringer Science and Business Media LLCCRISPR-based ex vivo gene editing of donor organs
- Publisher
- Springer Science and Business Media LLC
- Date
- Jun 29, 2026
- Trust tier
- crossref
- License
- https://www.springernature.com/gp/researchers/text-and-data-mining
SourceSpringer NatureA comprehensive review of CRISPR-Cas9-mediated genome editing in Leishmania strains: methodologies, applications, challenges and future directions
- Publisher
- Springer Nature
- Date
- Jul 9, 2026
- Trust tier
- openalex
- License
- Not specified
SourceSpringer Science and Business Media LLCInducing physiological polarity and performing gene editing using CRISPR–Cas9 in human trophoblast organoids
- Publisher
- Springer Science and Business Media LLC
- Date
- Jun 29, 2026
- Trust tier
- crossref
- License
- https://www.springernature.com/gp/researchers/text-and-data-mining
SourceClinicalTrials.govTipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
- Publisher
- ClinicalTrials.gov
- Date
- Jul 15, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record
SourceSAGE PublicationsEditing the Binary: CRISPR, Intersex Erasure, and the Feminist Ethics of Social Work
- Publisher
- SAGE Publications
- Date
- Jul 11, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceTheoretical and Natural ScienceResearch Progress of CRISPR-Cas Technology in the Treatment of Monogenic Diseases
- Publisher
- Theoretical and Natural Science
- Date
- Jul 6, 2026
- Trust tier
- openalex
- License
- cc-by
SourceFrontiers Media SAThe application of CRISPR gene-editing technology in influenza prevention and control
- Publisher
- Frontiers Media SA
- Date
- Jun 25, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/
SourceBentham Science Publishers Ltd.Gene Editing for Tuberculosis using CRISPR-Cas Technology
- Publisher
- Bentham Science Publishers Ltd.
- Date
- Jul 16, 2026
- Trust tier
- crossref
- License
- https://creativecommons.org/licenses/by/4.0/legalcode
SourceCell PressExpansion, functional diversification, and gene fusion events in the Ato protein family
- Publisher
- Cell Press
- Date
- Jun 23, 2026
- Trust tier
- openalex
- License
- cc-by
SourceCold Spring Harbor LaboratorySynergistic CRISPR-Cas Antimicrobials through Essential and Defensive Gene Cotargeting in <i>Staphylococcus aureus</i>
- Publisher
- Cold Spring Harbor Laboratory
- Date
- Jun 27, 2026
- Trust tier
- openalex
- License
- Not specified
SourceSpringer Science+Business MediaCRISPR/Cas9 Mediated Genome Editing for Enhancing Abiotic Stress Tolerance in Rice: An Omics Guided Perspective
- Publisher
- Springer Science+Business Media
- Date
- Jun 23, 2026
- Trust tier
- openalex
- License
- Not specified
SourceFrontiers MediaBeyond GMOs: transgene-free gene-edited crops for global food security
- Publisher
- Frontiers Media
- Date
- Jul 10, 2026
- Trust tier
- openalex
- License
- cc-by
SourceElsevier BVCRISPR approaches: Modeling tumor-stroma interactions and their role in cancer progression
- Publisher
- Elsevier BV
- Date
- Jun 22, 2026
- Trust tier
- openalex
- License
- Not specified
SourcePleiades PublishingOptimization of a Genome Editing System for Lactococci Based on a CRISPR-Associated Transposon
- Publisher
- Pleiades Publishing
- Date
- Jul 17, 2026
- Trust tier
- openalex
- License
- Not specified
SourceClinicalTrials.govEvaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
- Publisher
- ClinicalTrials.gov
- Date
- Jul 1, 2026
- Trust tier
- clinical-trials
- License
- ClinicalTrials.gov public registry record